These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8737443)

  • 1. Molecular modeling of interactions between tetrahydroprotoberberines and dopamine receptors.
    Tang Y; Chen KX; Jiang HL; Jin GZ; Ji RY
    Zhongguo Yao Li Xue Bao; 1996 Jan; 17(1):8-12. PubMed ID: 8737443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling of mu opioid receptor and its interaction with ohmefentanyl.
    Tang Y; Chen KX; Jiang HL; Wang ZX; Ji RY; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):156-60. PubMed ID: 9772668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of tetrahydroprotoberberines on dopamine D1 and D2 receptors in calf striatum.
    Guo X; Wang LM; Liu J; Jin GZ
    Zhongguo Yao Li Xue Bao; 1997 May; 18(3):225-30. PubMed ID: 10072938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tetrahydroprotoberberines on dopamine receptor subtypes in brain.
    Xu SX; Yu LP; Han YR; Chen Y; Jin GZ
    Zhongguo Yao Li Xue Bao; 1989 Mar; 10(2):104-10. PubMed ID: 2530755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D1 receptor agonist and D2 receptor antagonist effects of the natural product (-)-stepholidine: molecular modeling and dynamics simulations.
    Fu W; Shen J; Luo X; Zhu W; Cheng J; Yu K; Briggs JM; Jin G; Chen K; Jiang H
    Biophys J; 2007 Sep; 93(5):1431-41. PubMed ID: 17468175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tetrahydroprotoberberines on dopamine D2 receptors in ventral tegmental area of rat.
    Wang LM; Zhang XX; Jin GZ
    Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):143-6. PubMed ID: 10072967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric total synthesis and identification of tetrahydroprotoberberine derivatives as new antipsychotic agents possessing a dopamine D(1), D(2) and serotonin 5-HT(1A) multi-action profile.
    Sun H; Zhu L; Yang H; Qian W; Guo L; Zhou S; Gao B; Li Z; Zhou Y; Jiang H; Chen K; Zhen X; Liu H
    Bioorg Med Chem; 2013 Feb; 21(4):856-68. PubMed ID: 23332346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective pharmacophore models of dopamine D(1) and D(2) full agonists based on extended pharmacophore features.
    Malo M; Brive L; Luthman K; Svensson P
    ChemMedChem; 2010 Feb; 5(2):232-46. PubMed ID: 20077461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
    J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
    J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular modeling of mu opioid receptor and receptor-ligand interaction.
    Rong SB; Zhu YC; Jiang HL; Zhao SR; Wang QM; Chi ZQ; Chen KX; Ji RY
    Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):317-22. PubMed ID: 10072913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2,3,9- and 2,3,11-trisubstituted tetrahydroprotoberberines as D2 dopaminergic ligands.
    Párraga J; Cabedo N; Andujar S; Piqueras L; Moreno L; Galán A; Angelina E; Enriz RD; Ivorra MD; Sanz MJ; Cortes D
    Eur J Med Chem; 2013 Oct; 68():150-66. PubMed ID: 23974015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of (+/-)12-chloroscoulerine on brain dopamine receptors].
    Chen LJ; Xi Y; Pang DW; Zhou QT; Jin GZ
    Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):185-9. PubMed ID: 9772676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical synthesis, microbial transformation and biological evaluation of tetrahydroprotoberberines as dopamine D1/D2 receptor ligands.
    Ge H; Zhang Y; Yang Z; Qiang K; Chen C; Sun L; Chen M; Zhang J
    Bioorg Med Chem; 2019 May; 27(10):2100-2111. PubMed ID: 30981605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the role of the receptor protein motifs possibly involved in electrostatic interactions on the dopamine D1 and D2 receptor oligomerization.
    Łukasiewicz S; Faron-Górecka A; Dobrucki J; Polit A; Dziedzicka-Wasylewska M
    FEBS J; 2009 Feb; 276(3):760-75. PubMed ID: 19143836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic treatment with (-)-stepholidine alters density and turnover of D1 and D2 receptors in striatum.
    Zou LL; Cai ST; Jin GZ
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):485-9. PubMed ID: 9863137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of C9 alkoxy analogues of (-)-stepholidine as dopamine receptor ligands.
    Madapa S; Gadhiya S; Kurtzman T; Alberts IL; Ramsey S; Reith M; Harding WW
    Eur J Med Chem; 2017 Jan; 125():255-268. PubMed ID: 27688181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biphasic firing response of nucleus accumbens neurons elicited by THPB-18 and its correlation with DA receptor subtypes.
    Fu Y; Zhu ZT; Zhu XZ; Jin GZ
    Acta Pharmacol Sin; 2004 Dec; 25(12):1597-605. PubMed ID: 15569403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modeling of interaction between delta opioid receptor and 3-methylfentanylisothiocyanate.
    Rong SB; Jiang HL; Chi ZQ; Chen KX; Zhu YC; Ji RY
    Zhongguo Yao Li Xue Bao; 1997 May; 18(3):219-24. PubMed ID: 10072937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.